
Katherine Peebles
Examiner (ID: 4540, Phone: (571)272-6247 , Office: P/1617 )
| Most Active Art Unit | 1617 |
| Art Unit(s) | 1617 |
| Total Applications | 612 |
| Issued Applications | 200 |
| Pending Applications | 118 |
| Abandoned Applications | 320 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18434333
[patent_doc_number] => 20230181627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-15
[patent_title] => NON-AQUEOUS LIQUID AND SEMI-SOLID FORMULATIONS OF AMORPHOUS CALCIUM CARBONATE
[patent_app_type] => utility
[patent_app_number] => 18/106735
[patent_app_country] => US
[patent_app_date] => 2023-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16002
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18106735
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/106735 | NON-AQUEOUS LIQUID AND SEMI-SOLID FORMULATIONS OF AMORPHOUS CALCIUM CARBONATE | Feb 6, 2023 | Abandoned |
Array
(
[id] => 18626502
[patent_doc_number] => 20230285288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-14
[patent_title] => NANOPARTICLE COMPOSITIONS COMPRISING CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 18/106659
[patent_app_country] => US
[patent_app_date] => 2023-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11153
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18106659
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/106659 | NANOPARTICLE COMPOSITIONS COMPRISING CANNABINOIDS | Feb 6, 2023 | Abandoned |
Array
(
[id] => 18877573
[patent_doc_number] => 20240000942
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-04
[patent_title] => Craniofacial implant made of polyether ether ketone (PEEK) with deposits to store and release active substances or active Ingredient
[patent_app_type] => utility
[patent_app_number] => 18/158051
[patent_app_country] => US
[patent_app_date] => 2023-01-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10295
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 300
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18158051
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/158051 | Craniofacial implant made of polyether ether ketone (PEEK) with deposits to store and release active substances or active Ingredient | Jan 22, 2023 | Pending |
Array
(
[id] => 19845078
[patent_doc_number] => 20250090429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-03-20
[patent_title] => UV FILTER COMPOSITIONS COMPRISING HYBRID METAL OXIDE PARTICLES
[patent_app_type] => utility
[patent_app_number] => 18/729532
[patent_app_country] => US
[patent_app_date] => 2023-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17367
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -33
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18729532
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/729532 | UV FILTER COMPOSITIONS COMPRISING HYBRID METAL OXIDE PARTICLES | Jan 16, 2023 | Pending |
Array
(
[id] => 19799091
[patent_doc_number] => 20250065016
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => METHOD AND KIT FOR TREATING A DAMAGED CONNECTIVE TISSUE
[patent_app_type] => utility
[patent_app_number] => 18/723323
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2478
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18723323
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/723323 | METHOD AND KIT FOR TREATING A DAMAGED CONNECTIVE TISSUE | Dec 19, 2022 | Pending |
Array
(
[id] => 19768264
[patent_doc_number] => 20250049690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => COMPOSITION COMPRISING HYALURONIC ACID-BASED POLYION COMPLEX PARTICLE AND SURFACTANT
[patent_app_type] => utility
[patent_app_number] => 18/719683
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18719683
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/719683 | COMPOSITION COMPRISING HYALURONIC ACID-BASED POLYION COMPLEX PARTICLE AND SURFACTANT | Dec 5, 2022 | Pending |
Array
(
[id] => 19784059
[patent_doc_number] => 20250057738
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-20
[patent_title] => COSMETIC SWEAT MANAGEMENT COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/719387
[patent_app_country] => US
[patent_app_date] => 2022-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2058
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18719387
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/719387 | COSMETIC SWEAT MANAGEMENT COMPOSITIONS | Dec 1, 2022 | Pending |
Array
(
[id] => 19743831
[patent_doc_number] => 20250032396
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-30
[patent_title] => A SKIN CARE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 18/715134
[patent_app_country] => US
[patent_app_date] => 2022-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3203
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18715134
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/715134 | A SKIN CARE COMPOSITION | Nov 30, 2022 | Pending |
Array
(
[id] => 19134507
[patent_doc_number] => 11969416
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2024-04-30
[patent_title] => Compactable oral formulations of ibutamoren
[patent_app_type] => utility
[patent_app_number] => 18/057941
[patent_app_country] => US
[patent_app_date] => 2022-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 17012
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 189
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18057941
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/057941 | Compactable oral formulations of ibutamoren | Nov 21, 2022 | Issued |
Array
(
[id] => 19707844
[patent_doc_number] => 20250017986
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-16
[patent_title] => SPRAY-DRIED COMPOSITIONS AND METHODS OF PREPARATION
[patent_app_type] => utility
[patent_app_number] => 18/705455
[patent_app_country] => US
[patent_app_date] => 2022-10-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18705455
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/705455 | SPRAY-DRIED COMPOSITIONS AND METHODS OF PREPARATION | Oct 25, 2022 | Pending |
Array
(
[id] => 18610805
[patent_doc_number] => 20230277535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-09-07
[patent_title] => THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/970192
[patent_app_country] => US
[patent_app_date] => 2022-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13775
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970192
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/970192 | THERAPEUTIC COMPOSITIONS, COMBINATIONS, AND METHODS OF USE | Oct 19, 2022 | Abandoned |
Array
(
[id] => 18361819
[patent_doc_number] => 20230143410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-11
[patent_title] => LINEZOLID FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/967783
[patent_app_country] => US
[patent_app_date] => 2022-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16983
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17967783
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/967783 | LINEZOLID FORMULATIONS | Oct 16, 2022 | Abandoned |
Array
(
[id] => 18267072
[patent_doc_number] => 20230088314
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => Composition For Surface Modification
[patent_app_type] => utility
[patent_app_number] => 17/966148
[patent_app_country] => US
[patent_app_date] => 2022-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18233
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 114
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17966148
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/966148 | Composition for surface modification | Oct 13, 2022 | Issued |
Array
(
[id] => 18254565
[patent_doc_number] => 20230081604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => TREATMENT OF ANASTOMOSES
[patent_app_type] => utility
[patent_app_number] => 17/965157
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6698
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17965157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/965157 | TREATMENT OF ANASTOMOSES | Oct 12, 2022 | Pending |
Array
(
[id] => 19111151
[patent_doc_number] => 20240122901
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-18
[patent_title] => AQUEOUS PHARMACEUTICAL COMPOSITION OF NITROFURANTOIN
[patent_app_type] => utility
[patent_app_number] => 17/963530
[patent_app_country] => US
[patent_app_date] => 2022-10-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17963530
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/963530 | AQUEOUS PHARMACEUTICAL COMPOSITION OF NITROFURANTOIN | Oct 10, 2022 | Pending |
Array
(
[id] => 20633383
[patent_doc_number] => 12594246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-04-07
[patent_title] => Formulations for enteric delivery of therapeutic agents
[patent_app_type] => utility
[patent_app_number] => 17/958815
[patent_app_country] => US
[patent_app_date] => 2022-10-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 31
[patent_no_of_words] => 11137
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 271
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17958815
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/958815 | Formulations for enteric delivery of therapeutic agents | Oct 2, 2022 | Issued |
Array
(
[id] => 19585041
[patent_doc_number] => 20240382598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-21
[patent_title] => LIPID FORMULATIONS FOR THE PREPARATION OF HEALTH INGREDIENT-CONTAINING HOT DRINKS
[patent_app_type] => utility
[patent_app_number] => 18/690807
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8246
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18690807
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/690807 | LIPID FORMULATIONS FOR THE PREPARATION OF HEALTH INGREDIENT-CONTAINING HOT DRINKS | Sep 8, 2022 | Pending |
Array
(
[id] => 19032607
[patent_doc_number] => 20240082422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-14
[patent_title] => METHOD FOR DELIVERING INSULIN
[patent_app_type] => utility
[patent_app_number] => 17/941384
[patent_app_country] => US
[patent_app_date] => 2022-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8541
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17941384
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/941384 | Method for delivering insulin | Sep 8, 2022 | Issued |
Array
(
[id] => 18126781
[patent_doc_number] => 20230012402
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => LONG-ACTING INJECTION DOSAGE FORM OF BETA 3 ADRENORECEPTOR AGONISTS
[patent_app_type] => utility
[patent_app_number] => 17/930713
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14654
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17930713
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/930713 | LONG-ACTING INJECTION DOSAGE FORM OF BETA 3 ADRENORECEPTOR AGONISTS | Sep 7, 2022 | Abandoned |
Array
(
[id] => 18091299
[patent_doc_number] => 20220409640
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => METHODS USING PHOSPHATIDYLSERINE POWDER
[patent_app_type] => utility
[patent_app_number] => 17/929461
[patent_app_country] => US
[patent_app_date] => 2022-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17929461
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/929461 | METHODS USING PHOSPHATIDYLSERINE POWDER | Sep 1, 2022 | Abandoned |